X J Guo, Y Yang, G X Wang, Y Cao, X X Hu, C H Jiang
{"title":"[序贯cd19靶向嵌合抗原受体T细胞治疗和阿扎胞苷联合venetoclax治疗异基因造血干细胞移植后复发的混合表型急性白血病1例报道]。","authors":"X J Guo, Y Yang, G X Wang, Y Cao, X X Hu, C H Jiang","doi":"10.3760/cma.j.cn121090-20241203-00528","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":24016,"journal":{"name":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","volume":"46 5","pages":"479"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12268289/pdf/","citationCount":"0","resultStr":"{\"title\":\"[Sequential CD19-targeted chimeric antigen receptor T cell therapy and azacitidine with venetoclax for relapsed mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report].\",\"authors\":\"X J Guo, Y Yang, G X Wang, Y Cao, X X Hu, C H Jiang\",\"doi\":\"10.3760/cma.j.cn121090-20241203-00528\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":24016,\"journal\":{\"name\":\"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\",\"volume\":\"46 5\",\"pages\":\"479\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12268289/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3760/cma.j.cn121090-20241203-00528\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/cma.j.cn121090-20241203-00528","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
[Sequential CD19-targeted chimeric antigen receptor T cell therapy and azacitidine with venetoclax for relapsed mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report].